DK3452609T3 - Fremgangsmåde til screening af antibakterielle forbindelser som inhibitor af mfd - Google Patents

Fremgangsmåde til screening af antibakterielle forbindelser som inhibitor af mfd Download PDF

Info

Publication number
DK3452609T3
DK3452609T3 DK17723952.2T DK17723952T DK3452609T3 DK 3452609 T3 DK3452609 T3 DK 3452609T3 DK 17723952 T DK17723952 T DK 17723952T DK 3452609 T3 DK3452609 T3 DK 3452609T3
Authority
DK
Denmark
Prior art keywords
mfd
inhibitor
procedure
antibacterial compounds
screening antibacterial
Prior art date
Application number
DK17723952.2T
Other languages
English (en)
Inventor
Rao Nalini Rama
Didier Rognan
Didier Lereclus
Original Assignee
Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement
Centre Nat Rech Scient
Univ Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement, Centre Nat Rech Scient, Univ Strasbourg filed Critical Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement
Application granted granted Critical
Publication of DK3452609T3 publication Critical patent/DK3452609T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/20Screening of libraries
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60In silico combinatorial chemistry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Library & Information Science (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Evolutionary Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Computing Systems (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK17723952.2T 2016-05-03 2017-05-03 Fremgangsmåde til screening af antibakterielle forbindelser som inhibitor af mfd DK3452609T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16305514 2016-05-03
PCT/EP2017/060525 WO2017191184A1 (en) 2016-05-03 2017-05-03 Method of screening antibacterial compounds as inhibitor of mfd

Publications (1)

Publication Number Publication Date
DK3452609T3 true DK3452609T3 (da) 2021-01-04

Family

ID=56571268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17723952.2T DK3452609T3 (da) 2016-05-03 2017-05-03 Fremgangsmåde til screening af antibakterielle forbindelser som inhibitor af mfd

Country Status (5)

Country Link
US (1) US10865435B2 (da)
EP (1) EP3452609B1 (da)
DK (1) DK3452609T3 (da)
ES (1) ES2840006T3 (da)
WO (1) WO2017191184A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3868376A1 (en) 2020-02-21 2021-08-25 Institut national de recherche pour l'agriculture, l'alimentation et l'environnement Method of treating bacterial infections and pharmaceutical composition for treating bacterial infections

Also Published As

Publication number Publication date
WO2017191184A1 (en) 2017-11-09
US20190345532A1 (en) 2019-11-14
US10865435B2 (en) 2020-12-15
ES2840006T3 (es) 2021-07-06
EP3452609B1 (en) 2020-10-14
EP3452609A1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
DK3873903T3 (da) Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere
DK3656769T3 (da) Aryl-phosphor-oxygen-forbindelse som egfr-kinase-inhibitor
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3472167T3 (da) Heterocykliske forbindelser som immunomodulatorer
DK3436461T3 (da) Pyrrolotriazinforbindelser som tam-inhibitorer
DK3442947T3 (da) Aminsubstituerede aryl- eller heteroarylforbindelser som ehmt1- og ehmt2-hæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3294713T3 (da) Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer
DK3164130T3 (da) Heteroaryle forbindelser anvendelige som inhibatorer af sumo-aktiverende enzym
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3533796T3 (da) Aminopyrazolopyrimidinforbindelse anvendt som neutrof faktor tyrosinkinasereceptor inhibitor
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3368683T3 (da) Fremgangsmåde til kvantifikationen af pd-l1
MA46242A (fr) Composés inhibiteurs de bêta-lactamase
DK3204378T3 (da) N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen
DK3512857T3 (da) Spiro-bicykliske inhibitorer af menin-mll-interaktion
DK3762368T3 (da) Aminopyrazindiolforbindelser som pi3k-y-inhibitorer
DK3386991T3 (da) Polycykliske forbindelser som inhibitorer af bruton's tyrosinkinase
DK3681885T3 (da) Tetrahydro-imidazo-quinolinsammensætninger som cbp/p300-inhibitorer
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3592745T3 (da) Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer
DK3692039T3 (da) Enantiomerer af substituerede thiazoler som antivirale forbindelser